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System-based proteomic analysis of the interferon response in human liver cells <p>Interferons (IFNs) play a critical role in the host antiviral defense and are an essential component of current therapies against hepatitis  C virus (HCV), a major cause of liver disease worldwide. To examine liver-specific responses to IFN and begin to elucidate the mechanisms  of IFN inhibition of virus replication, we performed a global quantitative proteomic analysis in a human hepatoma cell line (Huh7) in the  presence and absence of IFN treatment using the isotope-coded affinity tag (ICAT) method and tandem mass spectrometry (MS/MS).</p>
Abstract
Background: Interferons (IFNs) play a critical role in the host antiviral defense and are an essential
component of current therapies against hepatitis C virus (HCV), a major cause of liver disease
worldwide. To examine liver-specific responses to IFN and begin to elucidate the mechanisms of
IFN inhibition of virus replication, we performed a global quantitative proteomic analysis in a human
hepatoma cell line (Huh7) in the presence and absence of IFN treatment using the isotope-coded
affinity tag (ICAT) method and tandem mass spectrometry (MS/MS).
Results: In three subcellular fractions from the Huh7 cells treated with IFN (400 IU/ml, 16 h) or
mock-treated, we identified more than 1,364 proteins at a threshold that corresponds to less than
5% false-positive error rate. Among these, 54 were induced by IFN and 24 were repressed by more
than two-fold, respectively. These IFN-regulated proteins represented multiple cellular functions
including antiviral defense, immune response, cell metabolism, signal transduction, cell growth and
cellular organization. To analyze this proteomics dataset, we utilized several systems-biology data-
mining tools, including Gene Ontology via the GoMiner program and the Cytoscape bioinformatics
platform.
Conclusions: Integration of the quantitative proteomics with global protein interaction data using
the Cytoscape platform led to the identification of several novel and liver-specific key regulatory
components of the IFN response, which may be important in regulating the interplay between
HCV, interferon and the host response to virus infection.
Background
Interferons (IFNs) were originally discovered as antiviral
proteins that inhibit virus replication [1]. Upon virus infec-
tion, IFNs are induced in mammalian cells and thus mediate
cellular homeostatic responses to virus infection. In addition
to their antiviral properties, IFNs are involved in many other
physiological processes including cell growth and prolifera-
tion, cell death, the immune response and other cellular
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defense mechanisms [2]. The IFN signaling pathway has been
extensively studied [3,4]. On binding of IFNs to their cognate
receptors, the JAK-STAT signal transduction pathway is trig-
gered, culminating in the transcription of IFN-stimulated
genes (ISGs) that mediate IFN function. The proteins
encoded by ISGs include, but are not limited to, many antivi-
ral effectors such as the double-stranded RNA-activated pro-
tein kinase PKR (which inhibits viral protein synthesis via
eIF2α phosphorylation), the 2'-5' oligoadenylate synthetase
(2'-5' OAS) (which activates RNase L to degrade viral RNA),
and the Mx GTPases (which block viral transport inside the
cell). Other ISGs include ISG56 (which inhibits translation
via eIF3) and the P200 family (which impairs cell prolifera-
tion through cellular factors such as NFκB, E2F, P53, c-Myc,
UBF-1, YY1, MyoD) [2].
Owing to its anti-growth and immune-response properties,
IFNs have been successfully applied as therapeutics against
several types of cancers and infectious diseases including
multiple sclerosis, hepatitis and genital warts [2,5]. One of the
most prominent clinical applications of IFNs is treatment of
patients infected by hepatitis C virus (HCV) [6]. HCV has
infected an estimated 3% of the world population [7]. In the
absence of a protective vaccine, the only useful therapeutic
regimen to date has been treatment using interferon-alpha
(IFN-α) together with ribavirin, a broad spectrum antiviral
nucleoside [8]. However, more than 50% of HCV-infected
patients showed low rates of response to this therapy, in par-
ticular patients infected by genotype-1 HCV which is a more
infectious sub-genotype among Americans and Europeans.
Therefore, further elucidation of the mechanism of IFN
response in liver cells could help development of more effec-
tive therapeutics against HCV.
Here we describe a quantitative proteomic analysis of the IFN
response in human liver carcinoma Huh7 cells using the iso-
tope-coded affinity tag (ICAT) method and mass spectrome-
try (MS). We compared the global protein expression profile
in human liver cells in the presence or absence of IFN-α treat-
ment. Protein identification and quantification were executed
and statistically verified using a suite of software tools,
including PeptideProphet [9], ProteinProphet [10] and
ASAPRatio [11]. By this analysis, we identified more than
1,300 proteins at a threshold that showed a false-positive rate
of less than 5%. Of these proteins, 54 were IFN-induced pro-
teins and 24 were IFN-repressed. These include previously
well studied IFN-regulated proteins as well as novel proteins.
The cellular functions of those proteins were analyzed on the
basis of the Gene Ontology [12], using the GoMiner program
[13] and the Cytoscape platform [14].
Results and discussion
Global proteomic analysis of IFN- and mock-treated 
Huh7 cells
To develop a systems-based understanding of the IFN
response of liver cells we carried out a global proteomic anal-
ysis on human liver carcinoma cells, Huh7, under conditions
of IFN or mock treatment. We chose the Huh7 cell line
because it is a widely studied cell model and has been used to
develop a unique cell system containing the HCV RNA repli-
con, which is the best cell model system to study HCV propa-
gation and infection [15]. We collected cells 16 hours after
treatment with either IFN (400 IU/ml) or mock treatment.
The time period and IFN dose were chosen on the basis of the
maximal response in gene expression obtained from previous
time-course studies on IFN responses using a microarray
approach [16,17]. To increase the coverage of protein identifi-
cation, we fractionated the cell lysates into cytoplasmic,
nuclear and membrane fractions and analyzed them individ-
ually by the ICAT method and tandem mass spectrometry
(MS/MS). For each fraction, the IFN- or mock-treated sam-
ples were labeled with either isotopically light (12C) or heavy
(13C) acid-cleavable ICAT reagents containing a biotin affinity
tag. The light and heavy samples were then combined, prote-
olyzed to peptides, and fractionated by high-performance
liquid chromatography (HPLC) cation-exchange
chromatography followed by avidin-affinity chromatography.
The purified isotopically labeled peptides were subject to
microcapillary HPLC (µLC) followed by electrospray tandem
mass spectrometry (ESI-MS/MS) using an ion trap [18,19].
The peptides were identified by matching peptide tandem
mass spectra to sequences in the human International Pro-
tein Index (IPI) database [20] using SEQUEST software [21].
Each assignment of a MS/MS spectrum to a peptide sequence
was statistically validated using the PeptideProphet software
tool, which uses the database search scores and peptide end
information to compute a probability score for each identified
peptide, on a scale of 0 (incorrect identification) to 1 (correct
identification) [9]. The peptide identifications were subse-
quently transformed into protein identifications with overall
probability scores using the ProteinProphet software tool
[10]. Assigning a probability score to each identified peptide/
protein is essential for prioritizing proteins for follow-up
analysis, for publication of data that are of consistent quality,
and for dataset comparisons. In this study, we identified and
quantified 1,190 unique proteins from all three fractions of
Huh7 cells with probability scores higher than 0.9 (error rate
≤ 1%) (see Additional data files 1-4 for the original data files)
[22]. A reduction of the protein probability scores to 0.4 pro-
vided 1,364 protein identifications. This threshold had a sen-
sitivity of 98% and a false-positive error rate of less than 5%.
Cellular fractionation improved protein identification, partic-
ularly for the nuclear and membrane proteins, which are usu-
ally less abundant than the cytoplasmic proteins (Figure 1a).http://genomebiology.com/2004/5/8/R56 Genome Biology 2004,     Volume 5, Issue 8, Article R54       Yan et al. R54.3
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In addition to statistically validating peptide/protein identifi-
cations, we also applied statistical analysis to protein quanti-
fication. In quantitative proteomics, changes in protein
abundance are determined by calculating the ratio of isotopi-
cally labeled peptides. The different isotopic peptides were
introduced by ICAT labeling (light for IFN and heavy for
mock in this study). The abundance ratios were calculated
using the ASAPRatio software tool [11]. The ratio for each
quantified peptide was calculated from multiple measure-
ments, including measurements of different charge states of
the same peptide, measurements of repeat MS analyses of the
same peptide from different cation-exchange chromatogra-
phy fractions, and repeat measurements of the same peptides
outside the dynamic exclusion windows of mass spectrome-
try. Protein abundance was subsequently calculated from the
ratios of all the peptides corresponding to the same protein.
Therefore, all protein ratios obtained in this study represent
the average ± error calculated from numerous independent
measurements. Such statistics-based data processing and
presentation is particularly critical for global quantitative
proteomics analysis, for which the possibility for multiple
repeat experiments is technically and economically restricted
at present.
Liver proteome representation
The 1,364 proteins identified in the study at a threshold of 5%
error rate were examined for their biological association to
Gene Ontology (GO) categories [12]. With the help of the
recently developed GoMiner program [13], we built a GO cat-
egory structure based on 9,400 human genes currently carry-
ing human GO annotations (used as Query Gene File). The
1,364 identified proteins from this study were then loaded as
Query Changed Gene File into the GoMiner program to exam-
ine the distribution of these proteins in the GO category struc-
ture. Although only 815 of the 1,364 identified proteins have
been currently annotated by the GO consortium, they already
covered, at level 3 of the GO ontology, all seven GO
'biological_process' categories, six of the seven
'cellular_component' (except 'immunoglobulin complex')
categories, and 27 of the 29 'molecular_function' (except 'ice
nucleation activity' and 'regulator of establishment of compe-
tence for transformation activity') categories (Figure 1b).
Therefore, the proteins identified in this study represent
most, if not all, GO-categorized cellular processes. A human
liver proteomic dataset consisting of more than 1,300 pro-
teins, which is publicly accessible at [23], is expected to be
useful for research on IFN signaling and liver diseases. The
dataset, together with its enriched information on human
liver protein/peptide identifications, GO categories, cellular
fractionations, cation exchange and reverse-phase chroma-
tography elution profiles, and so on, is also expected to be
useful as a reference for future human proteomics analyses.
In addition, it strongly suggests the feasibility of performing
large-scale proteomics analyses on the Huh7 cell-based HCV
replicon system to study cellular responses to HCV RNA
replication.
Profiling IFN-regulated protein expression
Application of the ICAT methodology in this study allowed us
to quantitatively compare protein-expression profiles
between IFN- and mock-treated Huh7 cells. The 1,364 identi-
fied proteins were quantified by the ratios of protein levels
between IFN- and mock-treated samples (Table 1). Upon IFN
treatment, 54 of these proteins displayed a more than two-
fold increase in level; these included 15 IFN-induced proteins
reported previously and 39 novel IFN-induced proteins.
Using the GoMiner program, we analyzed the biological clas-
sifications of the 54 IFN-induced proteins in the GO catego-
ries and found that they were enriched in defense-related
cellular pathways such as stress response, immune response,
signaling pathways and cell organization (Figure 2a). In con-
trast, the 24 IFN-repressed proteins were mostly associated
with cellular pathways such as cell metabolism, development
and RNA transport (Figure 2b) in the GO analysis. The novel
IFN-repressed proteins are particularly interesting as little is
known about the mechanisms underlying IFN downregula-
tion of gene expression.
Protein identification Figure 1 (see following page)
Protein identification. (a) Protein identification from the cytoplasmic (purple), membrane (blue) and nuclear (pink) fractions of the Huh7 cells. Numbers of 
identified proteins with p ≥ 0.4 are shown. (b) Proteins identified in this study covered most of the 'biological process', 'cellular components' and 
'molecular functions' categories at GO level 3. GO analysis was performed following the procedure described in [13]. Briefly, 16,477 human proteins 
currently carrying human GO nomenclatures were imported into the GoMiner program. Of the 16,477 human genes carrying GO annotations, 9,400 
were loaded as Query Gene File in the GoMiner program to build a GO category structure based on the GO annotation database (June 2003). The 1,364 
proteins were subsequently loaded as Query Changed Gene File in the GoMiner program to display coverage of the proteomics-identified proteins with 
respect to GO category. Of the 1,364 proteins, 815 that carry current GO annotations finally contributed to the coverage. (c) For immunoblot analysis, 
20 µg of each lysate from IFN-treated Huh7 cells at the indicated time points and dose was subjected to western blot analysis using antibodies as indicated. 
Data at the 16 h time point and 400 IU/ml IFN concentration, which are the conditions for proteomic analysis, are highlighted with a blue box.R54.4 Genome Biology 2004,     Volume 5, Issue 8, Article R54       Yan et al. http://genomebiology.com/2004/5/8/R56
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Figure 1 (see legend on previous page)
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Table 1
List of proteins up- or downregulated by two-fold or more by IFN in this study
IPI code Protein* p† Ratio‡ SD Number§
IFN-induced proteins
IPI00164222 ACACA: acetyl-coenzyme A carboxylase alpha 1.00 3.351 0.259 2
IPI00033030¶ ADRM1: adhesion regulating molecule 1 0.79 9.508c 1.043 1
IPI00012007¶ AHCY: S-adenosylhomocysteine hydrolase 0.93 6.279n 0.936 1
IPI00032958 ANLN: anillin, actin binding protein (scraps homolog, Drosophila) 0.43 2.420 0.129 1
IPI00004656 B2M: beta-2-microglobulin 1.00 2.768 0.583 8
IPI00027803 BAL: B aggressive lymphoma gene 0.96 2.835 0.184 1
IPI00171487 CABC1: chaperone, ABC1 activity of bc1 complex like (S. pombe) 0.99 3.533 1.659 2
IPI00015199 CD7: CD7 antigen (p41) 0.57 4.523 2.204 2
IPI00028275 CH-TOG : Colonic and hepatic tumor overexpressed protein 1.00 2.048 0.085 4
IPI00011284 COMT: catechol-O-methyltransferase 1.00 2.614 0.239 2
IPI00164416 CSA_PPIasePeptidyl prolyl cis trans isomerase 1.00 8.104 1.070 55
IPI00029485 DCTN1: dynactin 1 (p150, glued homolog, Drosophila) 0.99 2.183 0.133 1
IPI00163553 DKFZP564C186: DKFZP564C186 protein 1.00 2.108 0.505 3
IPI00061170 DNAH11: dynein, axonemal, heavy polypeptide 11 0.94 9999 -1 2
IPI00015947 DNAJB1: DnaJ (Hsp40) homolog, subfmaily B, member 1 0.89 2.571 0.223 1
IPI00031836 DRG1: developmentally regulated GTP binding protein 1 1.00 2.471 1.588 4
IPI00029536 EEF1A protein [Fragment] 1.00 3.035 0.624 5
IPI00010810 ETFA: electron-transfer-flavoprotein, alpha polypeptide 0.45 2.890 0.484 1
IPI00065180 FLJ32915: hypothetical protein FLJ32915 0.73 6.054 4.883 2
IPI00031773 FOXA2: forkhead box A2, hepatic nuclear factor-3-beta 0.99 2.640 1.678 1
IPI00007241 G1P2: IFN, alpha-inducible protein (clone IFI-15K) 0.98 4.858 0.661 1
IPI00028564 GBP1: guanylate binding protein 1, IFN-inducible 0.56 2.130 0.208 1
IPI00026268¶ GNB1:G protein, beta subunit 1 1.00 5.845n 0.133 2
IPI00171038 GPR111: G protein-coupled receptor 111 0.63 21.27 4.741 2
IPI00007404 APG7L: ubiquitin activating enzyme E1-like protein, GSA7 0.98 2.844 0.663 1
IPI00007853 IFI30: IFN, gamma-inducible protein 30 0.97 2.219 0.183 1
IPI00008613 IFI35: IFN-induced protein 35 1.00 2.223 0.426 2
IPI00018300 IFIT1: IFN-induced protein with tetratricopeptide repeats 1 0.48 9999 -1 1
IPI00024254 IFIT4: IFN-induced protein with tetratricopeptide repeats 4 1.00 6.230 0.794 6
IPI00026834 INPP5E: inositol polyphosphate-5-phosphatase, 72 kDa 1.00 2.470 0.399 2
IPI00059811 ISG20: IFN stimulated gene 20 kDa 0.88 2.303 0.319 1
IPI00032387 KIAA0186: KIAA0186 gene product 0.99 2.365 0.198 2
IPI00003499 KIAA1276: KIAA1276 protein 0.62 3.815 0.058 1
IPI00020096 KNS2: kinesin 2 60/70 kDa 1.00 3.140 0.335 2
IPI00013976 LAMB1: laminin, beta 1 0.94 2.693 0.180 2
IPI00152503 LOC151636: rhysin 2 1.00 2.975 0.231 4
IPI00000421 M96:mouse metal response element binding transcription factor 2 0.98 2.923 0.390 1
IPI00023399 MTP: microsomal triglyceride transfer protein (88 kDa) 0.97 4.748 0.751 1
IPI00024681 MX1: myxovirus resistance 1, IFN-inducible protein p78 0.93 2.300 0.204 1
IPI00012450 NMI: N-Myc (and STAT) interactor 0.57 2.875 0.138 1
IPI00000022 NUDT2: nucleoside diphosphate linked moiety X type motif 2 0.98 3.684 0.224 2
IPI00002405 OAS3: 2'-5'-oligoadenylate synthetase 3, 100 kDa 1.00 2.460 0.076 5
IPI00141040 PASK PAS domain containing serine/threonine kinase 0.49 12.006 1.024 2
IPI00024989 PCMT1: protein-L-isoaspartate (D-aspartate) O-methyltransferase 0.98 2.836 0.276 1
IPI00016461 PLCD1: phospholipase C, delta 1 0.69 4.569 0.116 1
IPI00019463 PKR protein kinase, IFN-inducible ds RNA dependent 1.00 3.963 0.659 3
IPI00008530 RPLP0: ribosomal protein, large, P0 1.00 2.044 0.198 3R54.6 Genome Biology 2004,     Volume 5, Issue 8, Article R54       Yan et al. http://genomebiology.com/2004/5/8/R56
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The antiviral defense and immune response
We then investigated the individual cellular pathways with
which the IFN-regulated proteins were associated. IFNs are
best known for their antiviral defense properties. Years of IFN
research have discovered several well known IFN-induced
proteins such as the protein kinase PKR, 2'-5' OAS, Mx, RNA-
specific adenosine deaminase (ADAR) and interferon regula-
tory factors (IRF) [2-4,24]. From this study, we identified all
these classical IFN-induced proteins except the IRFs. Missing
the IRFs is possibly due to the very low abundance of these
transcription factors inside the liver cell, resulting in a con-
centration that is below the sensitivity of our MS detection.
All these IFN-induced proteins were shown to be induced at
least two-fold upon IFN treatment with the exception of
ADAR (1.4-fold) (Table 1). Identification of these IFN-
induced proteins is consistent with a previous microarray
study performed by Williams and colleagues at the Cleveland
Clinic Foundation (Table 1, proteins in bold) [17,25]. We also
identified/quantified two IFN-induced proteins, STAT1 and
NMI, which are involved in the upstream IFN-related JAK/
IPI00021417 SART1: T-cell recognized squamous cell carcinoma antigen 0.57 2.616 0.093 1
IPI00030781¶ STAT1: large peptide, 91 kDa 1.00 2.153 m 0.079 9
IPI00024723 UBE2L6: ubiquitin-conjugating enzyme E2L 6 0.57 9999 -1 1
IPI00146772 ENSEMBL:ENSP00000295676 Tax_Id = 9606 0.78 3.240 0.955 2
IPI00062913 REFSEQ:XP_062729 hypothetical protein 0.46 3.073 2.000 1
IPI00045468 REFSEQ:XP_058770 Hypothetical protein 0.47 2.675 0.113 1
IPI00145529 REFSEQ:XP_167245 similar to seven-pass transmembrane receptor protein precursor and 
cyclophilin type peptidylprolyl isomerase A
1.00 2.29 0.448 5
IFN-repressed proteins
IPI00009137 CPSF4: cleavage and polyadenylation specific factor 4, 30 kDa 0.96 0.378 0.154 1
IPI00024549 FABP: fatty acid binding protein 0.93 0.328 0.041 1
IPI00004619 FACL4: fatty-acid-coenzyme A ligase, long-chain 4 0.98 0.416 0.081 1
IPI00026781 FASN: fatty acid synthase 0.99 0.304 0.100 137
IPI00016250 FXR2: fragile X mental retardation, autosomal homolog 2 0.95 0.391 0.074 1
IPI00011454 G2AN: alpha glucosidase II alpha subunit 1.00 0.198 0.033 13
IPI00156282 GPS1: G protein pathway suppressor 1 0.98 0.455 0.138 1
IPI00150148 HIC1: hypermethylated in cancer 1 0.94 0.000 -1 1
IPI00015587 Hypothetical protein FLJ21140 0.71 0.043 0.064 3
IPI00166489 IGLC3: Ig lambda chain C regions 0.98 0.265 0.11 2
IPI00055954 KIAA0007: KIAA0007 protein 1.00 0.426 0.014 2
IPI00166105 KRT10: keratin 10 0.97 0.495 0.055 2
IPI00022980 KRT6: keratin 6 1.00 0.003 0.008 14
IPI00017596 MAPRE1: RP/EB family, member 1 0.98 0.339 0.016 1
IPI00005948 MGC3207: hypothetical protein MGC3207 0.61 0.499 0.071 1
IPI00004399 MIG-6: Gene 33/Mig-6 0.99 0.000 -1 2
IPI00022334 OAT: ornithine aminotransferase 0.98 0.331 0.018 1
IPI00021794 PPGB: protective protein for beta-galactosidase (galactosialidosis) 1.00 0.323 0.084 8
IPI00034308 SARDH: sarcosine dehydrogenase 0.98 0.484 0.008 1
IPI00023344 SYMPK: symplekin 1.00 0.496 0.029 3
IPI00099730 SRRM2: serine/arginine repetitive matrix 2 0.82 0.434 0.224 1
IPI00027230¶ TRA1: tumor rejection antigen (gp96) 1 1.00 0.452 mn 0.165 4
IPI00166768¶ TUBA6: tubulin alpha 6 1.00 0.383 m 0.165 14
IPI00024693 WNT9A: wingless-type MMTV integration site family, member 9A 0.99 0.316 0.091 2
*Genes previously identified in the microarray study by Williams and colleagues [15] are shown in bold. †ProteinProphet probability score. ‡Ratio of 
IFN/mock. Ratio of 0.000 or 9999 indicates no detection of the IFN or mock signals, respectively. In either case the standard deviation is expressed 
as -1. §Number of peptides identified. ¶Proteins in which IFN-mediated expression was differentially regulated among the three cellular fractions in 
this study. Their ratios refer to specific cellular fractions as indicated: n, nuclear; m, membrane; c, cytoplasmic.
Table 1 (Continued)
List of proteins up- or downregulated by two-fold or more by IFN in this studyhttp://genomebiology.com/2004/5/8/R56 Genome Biology 2004,     Volume 5, Issue 8, Article R54       Yan et al. R54.7
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STAT signaling pathways. We performed western blot analy-
sis to confirm the protein expression patterns detected by
quantitative proteomics analysis (Figure 1c). We examined
the expression patterns of several IFN-induced proteins such
as PKR, NMI and STAT1 at multiple doses (0, 50, 200, 400
IU/ml) and multiple time points (8, 16, 40 and 72 hours).
These data indicate that the patterns observed by immunob-
lot analysis are consistent with the data obtained by quantita-
tive mass spectrometry and that the conditions used for the
proteomics analysis (16-hour treatment of IFN at 400 IU/ml
concentration) represented conditions of which an optimal
IFN response was observed (Figure 1c, boxed in blue).
In addition to coverage of many of the well characterized IFN-
induced proteins, our proteomic study also identified a signif-
icant number of proteins involved in the immune response,
which is also critical for IFN's antiviral activities. Applying
GO analysis to examine the biological classifications of the 54
IFN-induced proteins, we found that 11 were involved in the
immune response, which contributed to a 4.6-fold enrich-
ment at the GO category of 'immune response' (Figure 2a).
This is represented by the presence of β2-microglobulin and
IFI30, which are involved in MHC class I and MHC class II
antigen processing, respectively, as well as CD7, which plays
a role in T-cell activation (Figure 3). In addition, we identified
several IFN-induced immunomodulatory proteins that func-
tion in other cellular pathways and thus may have interesting
roles involving cross-talk between the immune response and
other cellular regulatory pathways. Examples include IFI35,
an IFN inducible protein involved in apoptosis; GBP1, a gua-
nine-nucleotide-binding protein involved in signaling path-
ways; and G1P2, an ubiquitin cross-reactive protein involved
in conjugating and targeting proteins to the cytoskeleton.
Interestingly, we also found IFIT1 and IFIT4, two IFN-
induced proteins with tetratricopeptide repeats (TPR motif),
which are involved in protein-protein interactions. However,
their molecular functions and potential interaction targets in
the immune response remain to be determined.
Cell metabolism and growth
IFN treatment has previously been shown to have pleiotropic
effects on many aspects of cell physiology, including cell
growth, proliferation, reorganization and death [2,4]. The
cellular response to stress conditions such as virus infection,
which induces high IFN levels, might be to reduce levels of
cellular metabolism. In support of this notion, we observed
that IFN suppressed expression of proteins involved in meta-
bolic pathways including fatty-acid metabolism (fatty acid
synthase (FASN); long-chain fatty-acid-coenzyme A ligase 4
(FACL4); and fatty-acid-binding proteins (FABP)), amino-
acid metabolism (ornithine aminotransferase (OAT); sarco-
sine dehydrogenase (SARDH); and FASN), nitrogen metabo-
lism (OAT), and DNA metabolism (tumor rejection antigen 1
(TRA1) involved in histone acetylation) (Figure 3).
IFN was previously reported to inhibit cell growth, possibly
through regulation of cell-cycle control [2]. In support of this,
we observed an induction of PKR by IFN treatment; PKR has
been reported to negatively regulate cell growth and prolifer-
ation [26]. Interestingly, information provided from the GO
analysis also revealed repression of protein MAPRE1, which
is an EB1 family member binding to APC (adenomatous poly-
posis coli), and is associated with the mitotic apparatus and
cell-cycle regulation [27,28].
Correlation of the cellular pathways
Acquisition of a large global proteomics dataset provides us
with a unique opportunity to analyze the IFN-mediated cellu-
lar pathways at a systems-based level. The results discussed
above suggest cross-talk between activation of the antiviral
defense pathways and suppression of pathways involved with
cell growth and proliferation. When applying GO analysis to
investigate the distribution of the 78 IFN-regulated (induced
and repressed) proteins in multiple cellular pathways, we
observed that many IFN-induced and repressed proteins may
be functionally related and react in a coordinated manner. As
shown in Figure 2, at the 'biological process' GO category
(level 2) and its subcategories, IFN-induced proteins were
enriched in several cellular defense-related pathways includ-
ing immune response, stress response and signal transduc-
tions (Figure 2a, red nodes) and were relatively depleted in
the categories of metabolism (Figure 2a, blue nodes). On the
other hand, the IFN-repressed proteins are more likely to be
enriched in the metabolic pathways (Figure 2b, red nodes)
but not in pathways such as those involved in cellular defense
mechanisms.
IFN signaling
Taking advantage of the global proteomics approach together
with systems-based data mining, we also successfully identi-
fied and quantified multiple components of the IFN signaling
pathways, including STAT1 and NMI in the JAK-STAT path-
way, Mx1 (a GTPase involved in the immune response, cellu-
lar organization and apoptosis), PASK (PAS-domain-
containing serine/threonine kinase in phosphate metabo-
lism), GPR111 and PLCD1 (G-protein signaling), GNB1 (G-
protein signaling and Ras signal transduction), GPS1 (G-pro-
tein, MAPK, and JNK signaling), WNT9A (Wnt signaling)
(Figure 3). The IFN-mediated differential expression of many
signaling molecules within the signal transduction network
strongly suggests a crosstalk among multiple signaling
pathways.
Of particular interest is the activation of the G-protein-cou-
pled receptor (GPCR) signaling pathway during the IFN
response. The GPCR signaling pathway has been widely stud-
ied. More than 1,000 GPCRs have been cloned, which regu-
late, at a minimum, the adenylate cyclase, phospholipase C,
and phosphodiesterase-mediated signal transduction path-
ways [29,30]. However, little is known about the regulation of
the IFN-stimulated G-protein signaling pathways.R54.8 Genome Biology 2004,     Volume 5, Issue 8, Article R54       Yan et al. http://genomebiology.com/2004/5/8/R56
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Figure 2 (see legend on next page)
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Interestingly, we observed a number of IFN-induced proteins
involved in the G-protein signaling pathways: GPR111 (upreg-
ulated 21.3-fold), GNB1 (5.8-fold), and PLCD1 (4.6-fold) (Fig-
ure 3). GPR111 is the G-protein-coupled receptor 111. GNB1 is
the β-subunit of G proteins and has crucial roles in both inosi-
tol trisphosphate (IP3)-coupled G-protein signaling and Ras
protein signal transduction. The phospholipase C family
member PLCD1 is a PIP2 phosphodiesterase (delta subunit)
and is also involved in IP3-coupled G-protein signaling. Curi-
ously, a G-protein pathway suppressor, GPS1 was downregu-
lated by IFN treatment (2.2-fold) in our study. Therefore,
induction of G-protein-coupled signaling molecules appeared
to be coordinated with downregulation of the G-protein path-
way suppressor protein. Observation of these multiple signal-
ing molecules involved with the GPCR pathways strongly
suggests an IFN-stimulated and GPCR-mediated signal
transduction. It is unclear whether this enrichment of the
series of G-protein signaling components is reflective of a
novel IFN-mediated signaling loop or just involves identifica-
tion of several components of the G-protein signaling
pathways.
In addition to the G-protein signaling, we also observed a
decreased expression of the Wnt signaling molecule WNT9A
on IFN treatment (downregulated 3.2-fold). The Wnt signal-
ing pathway is essential in development. Whether this down-
regulation of WNT9A is related to a stress-mediated
attenuation of cellular development awaits further study. The
Wnt signaling was also reported to regulate cell polarity, in
parallel with Cdc42 [31]. The regulation of the cell polarity
requires participation of APC, EB1 and activation of cell
organization involved with the dynein proteins of the
cytoskeleton [32]. Interestingly, we identified multiple com-
ponents of the cell-polarity signaling pathway using our
proteomic approach, including WNT9A, EB1 (MAPRE1) and
dynein (DNAH1, a large subunit of dynactin; and DCTN1,
ciliary dynein heavy chain 11), suggesting an IFN-mediated
regulation of cell polarity.
Novel IFN-regulated proteins and potential targets for 
future study
Among the IFN-regulated proteins we identified, proteins
hitherto not known to be regulated by IFN are of particular
interest as they may reveal important new functions of the
IFN response. For example, we discovered two new IFN-
induced proteins, ADRM1 and LAMB, that are cell adhesion
molecules and may be involved in IFN-mediated cell migra-
tion, attachment and cell-cell interactions. Interestingly,
these two proteins were both recently found to be downregu-
lated in microarray studies of liver biopsies from HCV-
infected patients (M. Smith, D. Thomas, and M.G.K.,
unpublished data). Two keratin proteins, KRT6 (keratin 6)
and KRT10 (keratin 10) were found to be repressed by IFN
treatment in our study. Keratins are important components
of the cytoskeleton and have important roles in cell migration
and invasion. Furthermore, one family member, keratin 19,
has previously been shown to be correlated with hepatocellu-
lar carcinoma metastasis [33].
Three molecular chaperones, CABC1, CSA PPIase, and
DNAJB1, were found to be induced by IFN, while another
protein with a protein-protective role, PPGB (protective pro-
tein for beta-galactosidase), was repressed by IFN. In addi-
tion, four IFN-induced proteins - G1P2, IFI30, PCMT1 and
UBE2L6 - were involved in ubiquitination and protein degra-
dation in response to stress signals. It is reasonable to specu-
late that protein degradation might be activated as a cellular
survival response.
Importantly, four IFN-regulated proteins were liver specific,
including CH-TOG (overexpressed in hepatomas), FOXA2
(also known as hepatocyte nuclear forkhead transcription
factor), MTP (lipid transfer to apoB in the endoplasmic retic-
ulum of human hepatoma cells), and FASN (a fatty-acid syn-
thase whose expression is regulated by liver X receptors).
Consistent with the antiviral role of IFN, we found that IFN
suppressed expression of two proteins, CPSF4 and TRA1,
which are known to be regulated during viral infection.
CPSF4 is a cleavage and polyadenylation-specific factor
which forms a complex with the influenza virus NS1 protein
to selectively block the nuclear export of cellular but not viral
mRNA [34]. TRA1, a stress-induced tumor rejection antigen
(gp96) 1, is involved in histone acetylation and chromatin
modification and associates with the RNA polymerase of the
hepatitis B virus [35].
Genome analysis of the IFN-regulated proteins
IFN can affect protein expression by directly regulating gene
expression or by controlling protein levels through indirect
cellular effectors. To learn more about the IFN regulation of
gene expression in our study, we examined the cis-acting
DNA elements in the promoter regions of the IFN-regulated
protein open reading frames (ORFs). One signature of IFN-
inducible genes is the presence of IFN-related transcription
elements such as the IFN-stimulated response element
(ISRE) and IRF-7 binding site [16]. We analyzed 45 IFN-
Distribution of IFN-regulated proteins at various levels of GO categories Figure 2 (see previous page)
Distribution of IFN-regulated proteins at various levels of GO categories. The 1,364 proteins identified were imported into the GoMiner program to 
generate a directed acyclic graph (DAG) based on current annotations in the GO database. Each node of the DAG represents one GO category at various 
levels. (a) Fifty-four IFN-induced and (b) 24 IFN-repressed proteins were used as queries and loaded into GoMiner to classify these proteins into each 
GO category. The distribution of these IFN-regulated proteins is represented by a different color at each node. The color indicates a 1.5-fold enrichment 
(red), depletion (blue) or no change (gray) of the IFN-regulated proteins compared with the distribution over all identified proteins at that level. Several 
critical GO categories are labeled.R54.10 Genome Biology 2004,     Volume 5, Issue 8, Article R54       Yan et al. http://genomebiology.com/2004/5/8/R56
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induced proteins with known promoter sequences. As shown
i n  T a b l e  2 ,  2 1  o f  t h e  4 5  g e n e s  ( 4 4 % )  e n c o d i n g  t h e  I F N -
induced proteins contain at least one cis-element of the ISRE,
GAS, IRF-3 or IRF-7 binding sites, suggesting possible direct
transcriptional regulation of these proteins. They include the
well annotated proteins discussed above, such as ACACA,
B2M, GBP1, IFIT1, IFIT4, MX1, NMI, OAS3, PKR, STAT1 and
UBE2L6. The other 24 genes appeared to lack these known
promoter sequences, suggesting an indirect regulation or the
presence of other, unknown, promoter elements. In a similar
promoter analysis of the IFN-repressed proteins we were
unable to identify common promoter regulatory sequence
patterns.
The protein-interaction network of the IFN-regulated 
proteins
To gain systematic insights into the novel functions of IFN-
regulated proteins, we examined the interactions between
these proteins using the software package Cytoscape as our
bioinformatics analysis platform. Cytoscape provides a
unique in silico approach to examine and display protein-
interaction networks based on available protein-protein
interactions characterized from previous biological studies
[36-38]. We loaded the more than 1,300 identified and quan-
tified proteins from our SBEAMS database into Cytoscape,
and identified 219 interactions. Of the total 219 interactions,
157 were directly obtained from publicly available protein
interaction databases including HPRD [39] and PreBIND
[40]. Expanding the search to additional databases such as
BIND [41] and a privately curated compiled 'yeast reference
network' [40,42-44], an extra 57 interactions were detected
Summary of cellular pathways of IFN-regulated proteins based on data analysis as described in the text Figure 3
Summary of cellular pathways of IFN-regulated proteins based on data analysis as described in the text. The IFN-induced proteins are shown in red and 
IFN-repressed proteins in green.
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as occurring between orthologs (NCBI HomoloGene database
[45]) of the reference proteins in Mus musculus, Saccharo-
myces cerevisiae and Drosophila melanogaster.
Figure 4 shows the proteins that have been implicated in pro-
tein-protein interactions and displayed within an interaction
network. The proteins' colors portray their IFN-mediated
expression changes: red for upregulation and green for down-
regulation with a threshold of two-fold. This visualization
approach allows us to analyze complex biological data at a
systems-based level by studying protein expression in con-
junction with their interactions. Although the current data-
bases are not nearly complete, a preliminary examination of
this network containing only 157 interacting nodes already
provides us with useful information that is easily overlooked
by traditional approaches. For example, we note an interac-
tion between two IFN-induced proteins, NMI and IFI35. NMI
is a Myc-interacting protein that also interacts with STATs
Table 2
Partial list of cis-DNA elements of IFN-induced proteins
Gene Position Strand Sequence Binding site
ACACA -1847 Rev GTTTCTTTTTC ISRE
-3800 Rev AGTTTCGGATTC IRF-7
B2M -167 GAAAAGGAAAC ISRE
-161 GAAACTGAAAAC IRF-7
-2738 Rev GCTTTCATTTTC ISRE/IRF-7
G1P2 -316 GAAAATGAAAC ISRE/IRF-7
-114 GAAAGGGAAACC ISRE/IRF-3
-108 GAAACCGAAAC(T) ISRE/IRF-3/IRF-7
GBP1 -128 Rev ACTTTCAGTTTC IRF-7
GSA7 185 Rev AATTTCATTTTC IRF-7
IFIT1 -143 Rev (A)GTTTCACTTTC ISRE/IRF-7
-405 GAAACTGAAAAT IRF-7
-2096 Rev AATTTCATTTTC IRF-7
IFIT4 -173 Rev (G)GTTTCATTTTC ISRE/IRF-7
-139 Rev (A)GTTTCACTTTC ISRE/IRF-7
ISG20 -86 GAAAGGAAAC ISRE
140 GAAACTGAAAC ISRE
KIAA0186 -609 GAAATGGAAAGC ISRE
KIAA1276 -1048 GAATCCGAAAAC ISRE
LAMB1 -3940 GAAAGGAAAGC ISRE
LOC151636 -94 GAAACTGAAAC(T) ISRE/IRF-7
MX1 -101 Rev GTTTCGTTTC ISRE
-56 Rev GTTTCATTTC ISRE
NMI -78 GAAAGTGAAATT IRF-7
NUDT2 -746 TTCCCGGAA GAS
-2530 Rev GTTTCCTTTC ISRE
OAS3 -170 GAAACGAAAC ISRE
-165 GAAACTGAAAGC ISRE/IRF-7
-34 GAAAACGAAACC ISRE/IRF-7
PCMT1 -1370 GAATTTGAAAAT IRF-7
PRKR -3617 GAAAGGAAAC ISRE
-374 Rev GTTTCCTTTC ISRE
RPLP0 -1089 GAAACGGAAAGT IRF-3
STAT1 39 Rev (A)GTTTCGCTTTC ISRE/IRF-3/IRF-7
UBE2L6 -1813 TTCCGGGAA GAS
44% of promoter sequences have at least one of the following consensus sequences: GAS, TTCCSGGAA; ISRE, GAAA(N){1,2}GAAA(G){0,1}C [16]; 
IRF-3, GAAASSGAAANY; IRF-7, GAAWNYGAAANY.R54.12 Genome Biology 2004,     Volume 5, Issue 8, Article R54       Yan et al. http://genomebiology.com/2004/5/8/R56
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and augments STAT-mediated transcription in response to
IFN and interleukin-2 (IL-2) [46,47]. Interaction of NMI with
IFI35 is induced by IFN [48,49] and dissociation of these two
proteins occurs during apoptosis [50]. Interestingly, these
two proteins are close to two other IFN-induced proteins,
PKR and EEF1A, in the network, mediated only by YY1 (Yin
and Yang 1). Both PKR and EEF1A are involved in transla-
tional regulation. YY1 is a transcription factor regulating a
variety of promoters including the IFN promoter [51]. YY1
was also found to correlate with c-Myc in
hepatocarcinogenesis [52]. As the number of known protein
interactions expands in the near future, such a Cytoscape-
assisted approach for analyzing large genomic/proteomic
datasets will dramatically increase our understanding of
Proteins identified in this study, as visualized by the Cytoscape platform Figure 4
Proteins identified in this study, as visualized by the Cytoscape platform. Orthologs of all significantly expressed proteins were identified in the NCBI 
HomoloGene database [45], and curated interactions among the proteins and their orthologs were added from the public HPRD [39], BIND [41] and 
PreBIND [40] databases as well as a privately curated 'yeast reference network' [40,42-44]. ICAT ratios are indicated by node colors as indexed with a 
two-fold threshold. Interactions are colored according to their source database, and ortholog-inferred interactions are drawn as dashed lines.
IFN/Mock < 0.5
IFN/Mock > 2
0.5 < IFN/Mock < 2
Not quantified
HPRD
PreBIND (Probable interactions)
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Node Edge Databasehttp://genomebiology.com/2004/5/8/R56 Genome Biology 2004,     Volume 5, Issue 8, Article R54       Yan et al. R54.13
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these systems and could assist in the discovery of many
potential targets for biological follow-up studies as well as
therapeutic development.
Conclusions
In summary, we performed large-scale proteomic analysis on
IFN-treated human liver cells and analyzed the large dataset
using a systems-biology approach. Data presented here both
confirmed earlier work and, more importantly, identified
novel IFN-regulated proteins and pathways. We propose a
general picture of IFN-mediated regulation involving com-
plex novel pathways and cross-talk between various cellular
pathways in responses to multiple environmental signals
(Figure 3). Such a systems-based proteomic study will extend
our understanding about the IFN-mediated liver physiology
and may ultimately lead to development of more efficient
therapies against virus infections such as HCV.
Materials and methods
Cell culture and IFN treatment
Human liver carcinoma cells (Huh7) were cultured in DMEM
containing 10% FBS, 100 U/ml penicillin and 100 U/ml strep-
tomycin at 37°C. In proteomics analysis, cells were treated for
16 h with 400 IU/ml recombinant IFN-α2b (Intron-A, Scher-
ing-Plough). In immunoblot experiments, cells were treated
for 8, 16, 40 or 72 h with 0, 50, 200 or 400 IU/ml IFN before
harvest.
Cell lysis and fractionation
Cells were collected in a hypotonic lysis buffer (50 mM Tris
pH 7.5, 5 mM MgCl2, 5 mM CaCl2, 1 mM DTT, 1 mM EDTA,
and 1× Protease Inhibitor Cocktail (Roche) and then lysed by
Dounce homogenization followed by centrifugation at 3,000g
for 15 min. The pellet obtained (P-3) was washed by buffer
containing 600 mM KCl to produce the nucleus fraction. The
supernatant (S-3) was subsequently centrifuged at 100,000g
for 2 h and generated the cytoplasm fraction (S-100) and the
membrane fraction (P-100).
ICAT labeling and mass spectrometry
The cytoplasm, membrane and nuclear fractions were ace-
tone-precipitated and resuspended in ICAT labeling buffer
(0.05% SDS, 50 mM Tris pH 8.3, 5 mM EDTA, and 6 M urea).
Each fractionated sample was labeled with the second gener-
ation ICAT reagents (acid cleavable), either in light (12C for
IFN-treated) or in heavy (13C for mock-treated) isotopes
(Applied Biosystems). Equal amounts of the two labeled
samples were combined and digested into peptides by trypsin
(Promega). ICAT-labeled peptides were subsequently puri-
fied by cation-exchange chromatography and avidin-affinity
chromatography. Peptide mixtures were then analyzed by
microcapillary HPLC-electrospray ionization (ESI)-MS/MS
using an ion-trap mass spectrometer (LCQ-DecaXP, Ther-
moFinnigan) as previously described [53].
Immunoblot analysis and antibodies
Immunoblot analysis was performed as previously described
[54]. The anti-PKR antibody was a gift from Ara Hovanessian
[55]. The anti-NMI antibody was generously provided by
Louie Naumovski at Stanford University (California, USA).
Antibodies against STAT1 (monoclonal antibody 9H2) and β-
actin (ab6276) were purchased from Cell Signaling Technol-
ogy and Abcam, respectively.
Data analysis and software
SEQUEST matches peptide tandem mass spectra to sequence
in the human IPI database [21]; PeptideProphet assigns a
probability to the identified peptide sequence [9], and Pro-
teinProphet assigns an overall probability to the protein iden-
tification [10]. To quantify protein ratio between IFN- and
mock-treated samples, the program ASAPRatio was used to
calculate the ICAT ratios [11]. To classify the identified
proteins into cellular pathways, GO [12] analysis was per-
formed using the GoMiner program [13]. All proteomics data
were stored and systematically analyzed at the Systems Biol-
ogy Experiment Analytical Management System (SBEAMS)
at the Institute for Systems Biology (ISB) [23]. The data were
visualized using Cytoscape, which was co-developed by ISB
and MIT [14,36].
Additional data files
The following additional data is available with the online ver-
sion of this paper: the original data files of the ICAT analyses
on the cytoplasmic (Additional data 1), membrane (Addi-
tional data 2) and nuclear (Additional data 3) fractions of
Huh7 cells. Each file contains all proteins identified in indi-
vidual experiment and only those with ProteinProphet prob-
ability score ≥ 0.4 (with an error rate ≤ 5%) are included for
data analysis in this article. The descriptions of each column
in these three data files are given in Additional data 4; the fig-
ure in this file indicates the distribution of the protein ratio
(ASAPRatio) of the proteins analyzed in this paper (Protein-
Prophet probability score ≥ 0.4) (y-axis: ASAPRatio ratio; x-
axis: protein number). A normalization factor of 0.8 was
obtained from this figure and used to normalize individual
protein ratios as shown in columns 'O' and 'P' of the three data
files. These data are also available at [23].
Additional data file 1 The original data file of the ICAT analysis on the cytoplasmic frac- tion of Huh7 cells The original data file of the ICAT analysis on the cytoplasmic frac- tion of Huh7 cells Click here for additional data file Additional data file 2 The original data file of the ICAT analysis on the membrane frac- tion of Huh7 cells The original data file of the ICAT analysis on the membrane frac- tion of Huh7 cells Click here for additional data file Additional data file 3 The original data file of the ICAT analysis on the nuclear fraction of  Huh7 cells The original data file of the ICAT analysis on the nuclear fraction of  Huh7 cells Click here for additional data file Additional data file 4 The descriptions of each column in the first three data files The descriptions of each column in the first three data files Click here for additional data file
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